Your browser doesn't support javascript.
loading
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.
Kiltz, Uta; Landewé, Robert B M; van der Heijde, Désirée; Rudwaleit, Martin; Weisman, Michael H; Akkoc, Nurullah; Boonen, Annelies; Brandt, Jan; Carron, Philippe; Dougados, Maxime; Gossec, Laure; Jongkees, Merryn; Machado, Pedro M; Marzo-Ortega, Helena; Molto, Anna; Navarro-Compán, Victoria; Niederman, Karin; Sampaio-Barros, Percival Degrava; Slobodin, Gleb; Van den Bosch, Filip E; van Tubergen, Astrid; van Weely, Salima; Wiek, Dieter; Braun, Juergen.
Afiliação
  • Kiltz U; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany uta.kiltz@elisabethgruppe.de.
  • Landewé RBM; Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.
  • van der Heijde D; Rheumatology, Zuyderland MC, Heerlen, The Netherlands.
  • Rudwaleit M; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Weisman MH; Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany.
  • Akkoc N; Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, Los Angeles, California, USA.
  • Boonen A; Department of Medicine, Division of Rheumatology, Celal Bayar University School of Medicine, Manisa, Turkey.
  • Brandt J; Internal Medicine, Division of Rheumatology, Maastrich University Medical Center, Maastricht, The Netherlands.
  • Carron P; Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands.
  • Dougados M; Rheumatology, Private Practice, Berlin, Germany.
  • Gossec L; Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Jongkees M; VIB Inflammation Research Center, Ghent, Belgium.
  • Machado PM; Hopital Cochin, Rheumatology, Université Paris Descartes, Paris, France.
  • Marzo-Ortega H; INSERM (U1153): Epidémiologie Clinique et Biostatistiques, PRES Sorbonne Paris-Cité, Paris, France.
  • Molto A; Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), UMR S 1136, Sorbonne Universite, Paris, France.
  • Navarro-Compán V; APHP, Rheumatology department, Hopital Universitaire Pitie Salpetriere, Paris, France.
  • Niederman K; Patient Research Partner, Amsterdam, The Netherlands.
  • Sampaio-Barros PD; MRC Centre for Neuromuscular Diseases, University College London, London, UK.
  • Slobodin G; Rheumatology, University College London Centre for Rheumatology, London, UK.
  • Van den Bosch FE; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Disease, University of Leeds Faculty of Medicine and Health, Leeds, UK.
  • van Tubergen A; INSERM (U1153): Epidémiologie Clinique et Biostatistiques, PRES Sorbonne Paris-Cité, Paris, France.
  • van Weely S; Rheumatology, Hopital Cochin, paris, Ile de France, France.
  • Wiek D; Department of Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain.
  • Braun J; School of Health Professions, Institute of Physiotherapy, Zurich University of Applied Sciences, Winterthur, Switzerland.
Ann Rheum Dis ; 79(2): 193-201, 2020 02.
Article em En | MEDLINE | ID: mdl-31604704
OBJECTIVES: The Assessment of SpondyloArthritis International Society (ASAS) aimed to develop a set of quality standards (QS) to help improve the quality of healthcare provided to adult patients affected by axial spondyloarthritis (axSpA) worldwide. METHODS: An ASAS task force developed a set of QS using a stepwise approach. First, key areas for quality improvement were identified, discussed, rated and agreed on. Thereafter, areas were prioritised and statements for the most important key areas were phrased on consensus. Appropriate quality measures were defined to allow quantification of the QS at the community level. RESULTS: The ASAS task force, consisting of 20 rheumatologists, two physiotherapists and two patients, selected and proposed 34 potential key areas for quality improvement which were then commented by 140 ASAS members and patients. Within that process three new key areas came up, which led to a re-evaluation of all 37 key areas by 120 ASAS members and patients. Five key areas were identified as most important to determine quality of care: referral including rapid access, rheumatology assessment, treatment, education/self-management and comorbidities. Finally, nine QS were agreed on and endorsed by the whole ASAS membership. CONCLUSIONS: ASAS successfully developed the first set of QS to help improving healthcare for adult patients with axSpA. Even though it may currently not be realistic to achieve the QS in all healthcare systems, they provide high-quality of care framework for patients with axSpA that should be aimed for.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Espondilartrite / Atenção à Saúde Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Espondilartrite / Atenção à Saúde Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article